JPS57114512A - Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative - Google Patents
Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivativeInfo
- Publication number
- JPS57114512A JPS57114512A JP18401281A JP18401281A JPS57114512A JP S57114512 A JPS57114512 A JP S57114512A JP 18401281 A JP18401281 A JP 18401281A JP 18401281 A JP18401281 A JP 18401281A JP S57114512 A JPS57114512 A JP S57114512A
- Authority
- JP
- Japan
- Prior art keywords
- trimethyl ammonium
- ammonium derivative
- beticagent
- antidia
- carbamoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003472 antidiabetic agent Substances 0.000 title abstract 2
- 229940125708 antidiabetic agent Drugs 0.000 title abstract 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000002269 analeptic agent Substances 0.000 abstract 1
- 230000003555 analeptic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 230000001734 parasympathetic effect Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18401281A JPS57114512A (en) | 1981-11-17 | 1981-11-17 | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18401281A JPS57114512A (en) | 1981-11-17 | 1981-11-17 | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1989380A Division JPS56115715A (en) | 1980-02-20 | 1980-02-20 | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57114512A true JPS57114512A (en) | 1982-07-16 |
| JPS5751811B2 JPS5751811B2 (enExample) | 1982-11-04 |
Family
ID=16145782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18401281A Granted JPS57114512A (en) | 1981-11-17 | 1981-11-17 | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57114512A (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003061648A1 (en) * | 2002-01-25 | 2003-07-31 | Diamedica Inc. | Use of cholinesterase antagonists to treat insulin resistance |
| WO2005072713A3 (en) * | 2004-01-27 | 2005-12-08 | Long Island Jewish Res Inst | Cholinesterase inhibitors for treating inflammation |
| US9616015B2 (en) | 2012-05-25 | 2017-04-11 | Diamedica Inc. | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| US9839678B2 (en) | 2012-06-04 | 2017-12-12 | Diamedica Inc. | Human tissue kallikrein 1 glycosylation isoforms |
| US11857608B2 (en) | 2017-03-09 | 2024-01-02 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
-
1981
- 1981-11-17 JP JP18401281A patent/JPS57114512A/ja active Granted
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003061648A1 (en) * | 2002-01-25 | 2003-07-31 | Diamedica Inc. | Use of cholinesterase antagonists to treat insulin resistance |
| WO2005072713A3 (en) * | 2004-01-27 | 2005-12-08 | Long Island Jewish Res Inst | Cholinesterase inhibitors for treating inflammation |
| US8003632B2 (en) | 2004-01-27 | 2011-08-23 | The Feinstein Institute For Medical Research | Cholinesterase inhibitors for treating inflammation |
| US9616015B2 (en) | 2012-05-25 | 2017-04-11 | Diamedica Inc. | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| US9839678B2 (en) | 2012-06-04 | 2017-12-12 | Diamedica Inc. | Human tissue kallikrein 1 glycosylation isoforms |
| US11857608B2 (en) | 2017-03-09 | 2024-01-02 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
| US12329805B2 (en) | 2017-03-09 | 2025-06-17 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5751811B2 (enExample) | 1982-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5551020A (en) | Remedy for rheumatism | |
| JPS5767516A (en) | Novel analgesic agent | |
| JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
| JPS57114513A (en) | Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative | |
| JPS57114514A (en) | Antiphlogistic comprising (3-dimethylcarbamoxyphenyl) trimethyl ammonium derivative | |
| JPS57114515A (en) | Antipyr eticand analgesic comprising (3-dimethylcarbam- oxyphenyl)trimethyl ammonium derivative | |
| JPS54132239A (en) | Anti-tumor agent | |
| ES8602654A1 (es) | Procedimiento para la obtencion de nuevos derivados de la piperidina | |
| JPS56115715A (en) | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative | |
| JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
| JPS57128625A (en) | Carcinostatic | |
| JPS5536454A (en) | Novel immunosuppressive agent | |
| JPS57114519A (en) | Antiarteriosclerotic agent | |
| JPS5731616A (en) | Relaxing agent for muscle comprising benzofurancarboxylic acid amide | |
| JPS5498339A (en) | Carcinostatic agent | |
| JPS5759808A (en) | Remedy and preventive for digestive ulcer | |
| JPS54135231A (en) | Cardio-vasocular medicine | |
| JPS57114520A (en) | Antiarteriosclerotic agent | |
| JPS5569510A (en) | Carcinostatic agent | |
| JPS57112327A (en) | Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid | |
| JPS643120A (en) | Drug composition having inhibitory action on encephalopathy | |
| JPS5675430A (en) | Antiarteriosclerotic agent containing ethyl piperidylacetylaminobenzoate | |
| JPS5759809A (en) | Cardiotonic agent | |
| JPS57144216A (en) | Antiulcer | |
| JPS57126422A (en) | Stabilizing method of lysozyme pharmaceutical |